Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Virpax Pharmaceuticals Inc/
Recent news which mentions Virpax Pharmaceuticals Inc/
Lab Notes: AnPac dips into real estate with diversification strategy; Mineralys closes $220.8M IPO
February 17, 2023
Tickers
INNO
Tags
Haohan Xu
Pharmaceuticals
Bill & Melinda Gates Foundation
From
Business Journals
Lab Notes: FMC enters into a $200M bio-acquisition; Virpax going the OTC route again
July 08, 2022
Tickers
INNO
Tags
Medical Devices
Biotech
Immunome Inc/
From
Business Journals
Lab Notes: Endo acquires 6 product candidates for $35M; NiKang signs deal worth up to $218M
May 06, 2022
Tickers
INNO
Tags
Patricia Torr
Inno
Health Care
From
Business Journals
Lab Notes: Helius launches flagship product in U.S.; Virpax reports positive preclinical results for seizure drug
April 29, 2022
Tickers
INNO
Tags
Harmony Biosciences Holdings Inc/
Biotech
Inno
From
Business Journals
Virpax shares rise on expanded licensing deal for experimental drug
March 15, 2022
Tags
Insurance
Biotech
Christopher M/ Chipman
From
Business Journals
Lab Notes: LIMR awarded research grant; Virpax posts positive study results for pain treatment
January 21, 2022
Tickers
INNO
Tags
Hospitals
Insurance
Robert Moccia
From
Business Journals
Lab Notes: Lannett files FDA application for new drug; Virpax to start clinical trial for knee pain drug candidate
December 23, 2021
Tickers
INNO
Tags
Biotech
Anthony Mack
Roundup
From
Business Journals
Lab Notes: Arbutus and Penn make headway on Covid-19 treatments; Carisma partners with Merck
December 10, 2021
Tickers
INNO
Tags
Michael Klichinsky
Merck
Penn Medicine (University of Pennsylvania Health System)
From
Business Journals
Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and more
September 24, 2021
Tickers
INNO
Tags
Michael Klichinsky
Anthony P/ Mack
Jean/Pierre Issa
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.